Valchemy, Inc. – Trademark Portfolio
Entity Type: 03
Valchemy, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VALCHEMY. The owner is based in San Mateo, CA.
Suite 300
1825 South Grant
San Mateo, CA 94402
Showing of trademarks Trademarks
Trademark Classifications
Valchemy, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Valchemy, Inc. have?
Valchemy, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.
What trademark classes does Valchemy, Inc. file in?
Valchemy, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are Valchemy, Inc.'s most well-known trademarks?
Valchemy, Inc.'s registered trademark portfolio includes well-known marks such as VALCHEMY. These are among 1 currently registered trademark in the portfolio.
What is Valchemy, Inc.'s trademark registration success rate?
Valchemy, Inc. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.